These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 16563254

  • 1. [The role of first pass and delayed contrast-enhancement magnetic resonance imaging in patients with myocardial infarction].
    Ma JY, Qian JY, Ge JB, Yang S, Ge L, Liu XB, Lin JY, Hu XY, Zhang F, Zhang SH, Huang RC, Li YL, Shi HY, Fan B.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1027-30. PubMed ID: 16563254
    [Abstract] [Full Text] [Related]

  • 2. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
    Ma JY, Qian JY, Jin H, Chen ZW, Chang SF, Yang S, Sun AJ, Zeng MS, Zou YZ, Ge JB.
    Chin Med J (Engl); 2009 Mar 20; 122(6):687-91. PubMed ID: 19323935
    [Abstract] [Full Text] [Related]

  • 3. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study.
    Chiu CW, So NM, Lam WW, Chan KY, Sanderson JE.
    Radiology; 2003 Mar 20; 226(3):717-22. PubMed ID: 12601212
    [Abstract] [Full Text] [Related]

  • 4. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb 20; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV, Herzinfarktverbund Essen.
    Herz; 2008 Mar 20; 33(2):136-42. PubMed ID: 18344033
    [Abstract] [Full Text] [Related]

  • 6. Aborted myocardial infarction: evaluation of changes in area at risk, late gadolinium enhancement, and perfusion over time and comparison with overt myocardial infarction.
    Lee KH, Choi SI, Chun EJ, Kim JA, Lee MS, Yoon CH, Choi DJ.
    AJR Am J Roentgenol; 2012 Aug 20; 199(2):328-35. PubMed ID: 22826393
    [Abstract] [Full Text] [Related]

  • 7. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S, Solomon SD, Reynolds G, Kwong RY.
    J Cardiovasc Magn Reson; 2006 Aug 20; 8(6):831-7. PubMed ID: 17060106
    [Abstract] [Full Text] [Related]

  • 8. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B, Fenchel M, Hoevelborn T, Helber U, Scheule A, Claussen C, Miller S.
    Invest Radiol; 2006 Sep 20; 41(9):661-7. PubMed ID: 16896300
    [Abstract] [Full Text] [Related]

  • 9. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.
    Su MY, Yang KC, Wu CC, Wu YW, Yu HY, Tseng RY, Tseng WY.
    J Cardiovasc Magn Reson; 2007 Sep 20; 9(4):633-44. PubMed ID: 17578718
    [Abstract] [Full Text] [Related]

  • 10. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.
    Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM, Gadoversetamide Myocardial Infarction Imaging Investigators.
    Circulation; 2008 Feb 05; 117(5):629-37. PubMed ID: 18212288
    [Abstract] [Full Text] [Related]

  • 11. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.
    Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M.
    J Magn Reson Imaging; 2002 Dec 05; 16(6):633-40. PubMed ID: 12451576
    [Abstract] [Full Text] [Related]

  • 12. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A.
    Acad Radiol; 2006 Jul 05; 13(7):833-9. PubMed ID: 16777557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM, Ouyang H, Zhou CW.
    Zhonghua Zhong Liu Za Zhi; 2006 Feb 05; 28(2):111-5. PubMed ID: 16750014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.
    Yang Y, Connelly K, Graham JJ, Detsky J, Lee T, Walcarius R, Paul G, Wright GA, Dick AJ.
    J Magn Reson Imaging; 2011 Jan 05; 33(1):211-6. PubMed ID: 21182141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.